Skip to content

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02541292
Enrollment
10
Registered
2015-09-04
Start date
2016-02-29
Completion date
2018-11-30
Last updated
2018-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facioscapulohumeral Muscular Dystrophy 1a

Brief summary

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy with approximately 500 patients in Denmark. It is characterized by weakness and wasting of the facial muscles, the muscles in the shoulder region and of the legs. The primary aim of this study is to investigate possible links and order between inflammation and fat infiltration in the muscles in patients with FSHD. Approximately 15 patients with FSHD will be recruited for repeated MRI-scans during a year where the inflammation and fat infiltration in the muscles can be quantified.

Interventions

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed FSHD

Exclusion criteria

* All contraindications for undergoing an MRI scan

Design outcomes

Primary

MeasureTime frameDescription
Muscle inflammationOne MRI scan per subject (exam lasts approximately 60 min.)MRI (t2 mapping) will be used to quantify the inflammation in skeletal muscle.
Muscle fat fractionOne MRI scan per subject (exam lasts approximately 60 min.)The Dixon MRI will be used to quantify the fat fraction in skeletal muscle.

Secondary

MeasureTime frameDescription
Muscle strengthOne muscle strength test per subject (exam lasts approximately 60 min.)Isokinetic muscle dynamometry will be used to measure muscle strength.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026